Top 300 Pharmacy Drug Cards

MELOXICAM: Mobic, Various

Class: NSAID

Dosage Forms. Tablet: 7.5 mg, 15 mg; Suspension: 7.5 mg/5 mL


Common FDA Label Indication, Dosing, and Titration.

1. Osteoarthritis: 7.5 mg po daily, may titrate to max of 15 mg/d

2. Rheumatoid arthritis: 7.5 mg po daily, may titrate to max of 15 mg/d

3. Juvenile rheumatoid arthritis: Children 2 y and older, 0.125 mg/kg po daily, may titrate to max of 7.5 mg/d

Off-Label Uses. None

MOA. Nonselective inhibitor of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2), and reversibly alters platelet function and prolongs bleeding time.

Drug Characteristics: Meloxicam


Medication Safety Issues: Meloxicam


Drug Interactions: Meloxicam


Adverse Reactions: Meloxicam


Efficacy Monitoring Parameters. Decreased pain and improved range of motion.

Toxicity Monitoring Parameters. CBC, LFTs, SCr, fecal occult blood tests if chronic use. Seek medical attention if severe skin rash, black tarry stools, chest pains, yellowing of eyes or skin, or change in urination.

Key Patient Counseling Points. Take with food or milk to decrease GI upset. For suspension, shake gently before using.

Clinical Pearls. Elderly patients are at increased risk of GI ulceration. Use lowest effective dose for shortest possible duration; after observing initial response, adjust dose and frequency to meet individual patient’s needs.

If you find an error or have any questions, please email us at Thank you!